ONCAlert | Upfront Therapy for mRCC

Latest NewsMORE >>

Treatment with STP705 led to the achievement of complete histological clearance of squamous cell carcinoma in situ in a large proportion of patients, meeting the primary end point of the study, according to an interim analysis of the first 3 cohorts in an ongoing phase II clinical trial in patients with non-melanoma skin cancer announced by Sirnaomics Inc.
Feature:

COVID-19 Coverage: Learn More>>

Latest JournalAll Journals >>

Copyright © TargetedOnc 2020 Intellisphere, LLC. All Rights Reserved.